CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN
- 1 April 2017
- journal article
- research article
- Published by Elsevier in Experimental Gerontology
- Vol. 90, 83-89
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health (K25 AG043546, P30 AG028383, R01-AG044546, P01-AG003991, RF1AG053303, R01-AG035083, R21 AG050146)
- Alzheimer's Disease Neuroimaging Initiative (ADNI)
- National Institutes of Health (U01 AG024904)
- Department of Defense (W81XWH-12-2-0012)
- National Institute on Aging
- National Institute of Biomedical Imaging and Bioengineering
- AbbVie
- Alzheimer's Association
- Alzheimer's Drug Discovery Foundation
- Araclon Biotech
- BioClinica, Inc.
- Biogen
- Bristol-Myers Squibb Company
- CereSpir, Inc.
- Cogstate
- Eisai Inc.
- Elan Pharmaceuticals, Inc.
- Eli Lilly and Company
- EuroImmun
- F. Hoffmann-La Roche Ltd
- Genentech, Inc.
- Fujirebio
- GE Healthcare
- IXICO Ltd.
- Janssen Alzheimer Immunotherapy Research & Development, LLC
- Johnson & Johnson Pharmaceutical Research & Development LLC
- Lumosity
- Lundbeck
- Merck & Co., Inc.
- Meso Scale Diagnostics, LLC
- NeuroRx Research
- Neurotrack Technologies
- Novartis Pharmaceuticals Corporation
- Pfizer Inc.
- Piramal Imaging
- Servier
- Takeda Pharmaceutical Company
- Transition Therapeutics
- Canadian Institutes of Health Research
- NIH (P30 AG010129, K01 AG030514)
- Dana Foundation
- National Cell Repository for AD (NCRAD) (U24 AG21886)
- National Institute on Aging (AIG)
This publication has 46 references indexed in Scilit:
- Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative DementiasJournal of Alzheimer’s Disease, 2016
- Brain pathologies in extreme old ageNeurobiology of Aging, 2016
- The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plansAlzheimer's & Dementia, 2015
- Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related DementiasPLOS Genetics, 2014
- Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adultsNeurobiology of Aging, 2014
- TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer diseaseNeurology, 2012
- Rs5848 Variant Influences GRN mRNA Levels in Brain and Peripheral Mononuclear Cells in Patients with Alzheimer's DiseaseJournal of Alzheimer’s Disease, 2009
- TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous systemActa Neuropathologica, 2007
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- Clinical and Neuropathological Characteristics of Hippocampal SclerosisArchives of Neurology, 2002